Sam Awan, MD - Medicare Dermatology in Plano, TX

Sam Awan, MD is a medicare enrolled "Dermatology" physician in Plano, Texas. He graduated from medical school in 2014 and has 10 years of diverse experience with area of expertise as Dermatology. He is a member of the group practice Oliver Street 5.01(a) Inc and his current practice location is 5030 Tennyson Pkwy Ste 100, Plano, Texas. You can reach out to his office (for appointments etc.) via phone at (972) 985-9003.

Sam Awan is licensed to practice in Texas (license number R8151) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1013322858.

Contact Information

Sam Awan, MD
5030 Tennyson Pkwy Ste 100,
Plano, TX 75024
(972) 985-9003
(972) 985-1176



Physician's Profile

Full NameSam Awan
GenderMale
SpecialityDermatology
Experience10 Years
Location5030 Tennyson Pkwy Ste 100, Plano, Texas
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Sam Awan graduated from medical school in 2014
  NPI Data:
  • NPI Number: 1013322858
  • Provider Enumeration Date: 06/30/2014
  • Last Update Date: 06/03/2019
  Medicare PECOS Information:
  • PECOS PAC ID: 9436478716
  • Enrollment ID: I20181016003674

Medical Identifiers

Medical identifiers for Sam Awan such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1013322858NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207N00000XDermatology R8151 (Texas)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Oliver Street 5.01(a) Inc0042464125141

News Archive

Socioeconomic status more important barrier to living kidney donation than cultural factors

Socioeconomic status is a more important barrier to living kidney donation than cultural factors, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The findings may be useful for determining ways to increase living kidney donation in the United States.

Australian scientists sequence genome of pancreatic cancer

The International Cancer Genome Consortium which includes researchers from 22 countries is mapping the genomes of different types of cancers. A genome is essentially a blueprint of a human's DNA. The genetic data of each individual is different and so is the genetic data of the cancer in the individual. The Australian scientists are sequencing the genomes of people suffering from pancreatic cancer.

Compound may block COVID-19 virus from entering lung cells, study reports

Research conducted at LSU Health New Orleans Neuroscience Center of Excellence reports that Elovanoids, bioactive chemical messengers made from omega-3 very-long-chain polyunsaturated fatty acids discovered by the Bazan lab in 2017, may block the virus that causes COVID-19 from entering cells and protect the air cells (alveoli) of the lung.

Dr. Reddy's Laboratories launches Decitabine for Injection

Dr. Reddy's Laboratories announced today that it has launched Decitabine for Injection (50mg) a therapeutic equivalent generic version of Dacogen (Decitabine for Injection) in the US market on July 11, 2013, following the approval by the United States Food & Drug Administration of Dr. Reddy's ANDA for Decitabine for Injection.

Alzheimer's could be detected early using a blood test

Researchers from the ARTFL-LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) research consortium, have reported that a blood test could soon be an important diagnostic tool in detecting the abnormal proteins deposits in the brain that lead to the progressive and debilitating condition of Alzheimer's disease. The study titled, "Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration," was published in today's issue of the journal Nature Medicine.

Read more Medical News

› Verified 5 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Sam Awan allows following entities to bill medicare on his behalf.
Entity NameOliver Street 5.01(a) Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1457695413
PECOS PAC ID: 0042464125
Enrollment ID: O20130128000189

News Archive

Socioeconomic status more important barrier to living kidney donation than cultural factors

Socioeconomic status is a more important barrier to living kidney donation than cultural factors, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The findings may be useful for determining ways to increase living kidney donation in the United States.

Australian scientists sequence genome of pancreatic cancer

The International Cancer Genome Consortium which includes researchers from 22 countries is mapping the genomes of different types of cancers. A genome is essentially a blueprint of a human's DNA. The genetic data of each individual is different and so is the genetic data of the cancer in the individual. The Australian scientists are sequencing the genomes of people suffering from pancreatic cancer.

Compound may block COVID-19 virus from entering lung cells, study reports

Research conducted at LSU Health New Orleans Neuroscience Center of Excellence reports that Elovanoids, bioactive chemical messengers made from omega-3 very-long-chain polyunsaturated fatty acids discovered by the Bazan lab in 2017, may block the virus that causes COVID-19 from entering cells and protect the air cells (alveoli) of the lung.

Dr. Reddy's Laboratories launches Decitabine for Injection

Dr. Reddy's Laboratories announced today that it has launched Decitabine for Injection (50mg) a therapeutic equivalent generic version of Dacogen (Decitabine for Injection) in the US market on July 11, 2013, following the approval by the United States Food & Drug Administration of Dr. Reddy's ANDA for Decitabine for Injection.

Alzheimer's could be detected early using a blood test

Researchers from the ARTFL-LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) research consortium, have reported that a blood test could soon be an important diagnostic tool in detecting the abnormal proteins deposits in the brain that lead to the progressive and debilitating condition of Alzheimer's disease. The study titled, "Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration," was published in today's issue of the journal Nature Medicine.

Read more Medical News

› Verified 5 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Sam Awan is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Sam Awan, MD
5310 Harvest Hill Rd Ste 290,
Dallas, TX 75230-5826

Ph: (214) 420-0650
Sam Awan, MD
5030 Tennyson Pkwy Ste 100,
Plano, TX 75024

Ph: (972) 985-9003

News Archive

Socioeconomic status more important barrier to living kidney donation than cultural factors

Socioeconomic status is a more important barrier to living kidney donation than cultural factors, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The findings may be useful for determining ways to increase living kidney donation in the United States.

Australian scientists sequence genome of pancreatic cancer

The International Cancer Genome Consortium which includes researchers from 22 countries is mapping the genomes of different types of cancers. A genome is essentially a blueprint of a human's DNA. The genetic data of each individual is different and so is the genetic data of the cancer in the individual. The Australian scientists are sequencing the genomes of people suffering from pancreatic cancer.

Compound may block COVID-19 virus from entering lung cells, study reports

Research conducted at LSU Health New Orleans Neuroscience Center of Excellence reports that Elovanoids, bioactive chemical messengers made from omega-3 very-long-chain polyunsaturated fatty acids discovered by the Bazan lab in 2017, may block the virus that causes COVID-19 from entering cells and protect the air cells (alveoli) of the lung.

Dr. Reddy's Laboratories launches Decitabine for Injection

Dr. Reddy's Laboratories announced today that it has launched Decitabine for Injection (50mg) a therapeutic equivalent generic version of Dacogen (Decitabine for Injection) in the US market on July 11, 2013, following the approval by the United States Food & Drug Administration of Dr. Reddy's ANDA for Decitabine for Injection.

Alzheimer's could be detected early using a blood test

Researchers from the ARTFL-LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) research consortium, have reported that a blood test could soon be an important diagnostic tool in detecting the abnormal proteins deposits in the brain that lead to the progressive and debilitating condition of Alzheimer's disease. The study titled, "Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration," was published in today's issue of the journal Nature Medicine.

Read more News

› Verified 5 days ago


Dermatology Doctors in Plano, TX

Dr. Helena Jenkinson, M.D.
Dermatology
Medicare: Medicare Enrolled
Practice Location: 6100 Windhaven Pkwy, Plano, TX 75093
Phone: 972-608-0330    Fax: 214-615-1835
Timothy Robert Allen, MD
Dermatology
Medicare: Medicare Enrolled
Practice Location: 6100 Windhaven Pkwy, Plano, TX 75093
Phone: 214-615-1888    Fax: 706-222-4019
Dr. Elba I Rubianes, MD
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 6000 W Spring Creek Pkwy Ste 200, Plano, TX 75024
Phone: 972-316-4555    Fax: 214-285-0791
Dr. Mara Melanie Dacso, M.D
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 5044 Tennyson Pkwy, Suite B, Plano, TX 75024
Phone: 972-985-9003    Fax: 972-985-1176
Paul T Martinelli, M.D.
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 3585 National Dr Ste 150, Plano, TX 75025
Phone: 469-467-6647    Fax: 469-467-6648
Dr. Karen Ann Lund, M.D.
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 6100 Windhaven Parkway, Plano, TX 75093
Phone: 972-608-0330    Fax: 972-608-0355

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.